Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Tumor
1000-7431
2015 Issue 6
Hybridoma monoclonal antibody 15B7 targeting ESA-positive liver cancer stem cells inhibits cell invasion and cisplatin resistance in vitro
YANG Jing;MO Wen-xiu;LIU Hui-qi;YU Long;SUN Li-xin;YANG Zhi-hua;SUN Li-chao;RAN Yu-liang;State Key Laboratory of Molecular Oncology;Cancer Institute;Cancer Hospital;Chinese Academy of Medical Science & Peking Union Medical College;
..............page:597-603
CXCL8 siRNA inhibits proliferation and invasion of human colon carcinoma cells through PI3K/Akt/NF-κB signaling pathway
MA Jia-chi;LI Yuan;LI Yi-ping;FANG Wei;GUO Qing-jin;Department of General Surgery;Gansu Provincial Hospital;Graduate School;Ningxia Medical University;
..............page:604-612
Mutual antagonism of micro RNA-21 and BIM protein in the reversal of multidrug resistance to EGFR-TKIs in lung adenocaricinoma cells
WANG Qi;LI Jia-yu;LI Xue-fei;ZHAO Chao;CAI Wei-jing;CHENG Ning-ning;ZHAO Ming-chuan;ZHANG Li-min;PAN Hui;ZHOU Cai-cun;Department of Lung Cancer and Immunology;Shanghai Pulmonary Hospital of Tongji University;Cancer Institute of Tongji University School of Medicine;
..............page:613-620
Tetramethylpyrazine inhibits hypoxia-induced migration and invasion of breast cancer cell line MDA-MB-435S in vitro
SHAN Yun-long;WEI Zhong-hong;TAO Li;LIU Yu-ping;SHENG Xiao-bo;CHEN Chen;WU Hong-yan;CHEN Wen-xing;WANG Ai-yun;LU Yin;School of Pharmacy;Nanjing University of Chinese Medicine;Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica;School of Pharmacy;Nanjing University of Chinese Medicine;Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor;
..............page:621-629
Effects of anti-heparanase monoclonal antibody in combination with paclitaxel on proliferation, migration and invasion of breast cancer cell lines
GUO Ying;LUO Ya-yue;DONG Bin;DUAN Tao;LIN Yue-xia;TIAN Su-juan;Department of Biomedical Science;School of Biosciences and Biopharmaceutics;Guangdong Pharmaceutical University;
..............page:630-638
Expression of A20 gene in hepatocellular carcinoma patients and its prognostic signii cance
QIAO Peng;GAO Xiao-mei;YU Xin-xin;ZHANG Xiao-fei;DONG Qiong-zhu;QIN Lun-xiu;Department of General Surgery;Huashan Hospital;Fudan University;Liver Cancer Institute;Zhongshan Hospital;Fudan University;Institutes of Biomedical Sciences;Fudan University;
..............page:639-645
The level of serum VCAM-1 in patients with primar y hepatocellular carcinoma and its clinical signii cance
GE Chao;LI Hong;TU Hong;CHEN Tao-yang;XIE Hai-yang;CUI Ying;LI Jin-jun;State Key Laboratory of Oncogenes and Related Genes;Shanghai Cancer Institute;Renji Hospital;Shanghai Jiao Tong University School of Medicine;Qidong Liver Cancer Institute;Department of Hepatobiliary and Pancreatic Surgery;First Ai liated Hospital of Zhejiang University Medical College;Guangxi Cancer Institute;
..............page:646-652
Clinical outcomes of patients with cervical carcinoma receiving different radiochemotherapy regimens
WANG Xiao;XU Xiao-ting;LI Li;WANG Li-li;ZHOU Ju-ying;Department of Radiation Oncology;First Affiliated Hospital of Soochow University;
..............page:653-659
Application of DWI combined with MRI in diagnostic staging and decision of treatment method in patients with cervical cancer
LIAO Qiu-ling;ZHAO Ji-quan;ZHU Xin-jin;WANG Kang-ning;YANG Kan-rong;OU Wei-qian;LIN Zi-wei;OU Yang-fen;DONG Ju-lang;Graduate School of Guangdong Medical College;Medical Imaging Center;Second People’s Hospital of Foshan City;Department of Obstetrics and Gynecology;Second People’s Hospital of Foshan;
..............page:660-665
The expression of IFT20 protein in lung cancer tissues and its effect on the proliferation of lung cancer A549 cells
LIU Ge-li;LI Fei-long;HU Ning;PAN Jia-chuan;WANG Chang-dong;Department of Biochemistry and Molecular Biology;Molecular Medicine and Cancer Research Center;Chongqing Medical University;Depar tment of Orthopedics;First Affiliated Hospital of Chongqing Medical University;Chongqing;400016;China;Department of Biomedical and Chemical Engineering;Syracuse University;Syracuse;
..............page:666-674
Retrospective analysis of omitting clinical target volume for patients with stage Ⅲ non-small cell lung cancer treated with intensity-modulated radiotherapy
LIANG Xiang-cun;YU Rong;SHI An-hui;XU Gang;ZHU Guang-ying;Department of Radiation Oncology;Peking University Cancer Hospital/Beijing Institute for Cancer Research;Second Department of Lung Oncology;Hebei Provincial Chest Hospital;
..............page:675-682
The expression of Wnt2 in human breast cancer tissues and its effect on the invasion of breast cancer cells
XU Wei-yan;HOU Yi-feng;JIANG Xiao-fei;FENG Mao-hua;YUAN Hao;Department of General Surgery;Shanghai Pudong Hospital;Department of Breast Surgery;Fudan University Shanghai Cancer Center;
..............page:683-687
Association of CYP1A1*2C polymorphism with the susceptibility to childhood acute lymphoblastic leukemia: a Meta-analysis
ZOU ZE-qiao;YUE LI-jie;REN YAN-fei;Shenzhen Children’s Hospital;Zunyi Medical College;
..............page:688-695
Second primary malignancy in patient with multiple myeloma: a report of two cases and the review of literature
YUE Yuan-fang;MA Jing;LI Qian;LIU Su;CHEN Lin;LI Han;ZHAO Hai-feng;YANG Hong-liang;XIA Bing;YU Yong;WANG Xiao-fang;ZHANG Yi-zhuo;WANG Ya-fei;Department of Hematology and Blood and Marrow Transplantation of Tianjin Medical University Cancer Institute and Hospital;Tianjin Key Laboratory of Cancer Prevention and herapy;National Clinical Research Center for Cancer;
..............page:696-699
Advances in Eph receptor and its ligand Ephrin in tumor metastasis
ZHU Ping-ting;LIU Zhao-guo;LIU Yu-ping;SHAN Yun-long;WEI Zhong-hong;ZHOU Liang;TAO Li;WU Hong-yan;CAO Yu-zhu;SUN Li-hua;CHEN Wen-xing;WANG Ai-yun;LU Yin;School of Pharmacy;Nanjing University of Chinese Medicine;Department of Nursing;Medical School of Yangzhou University;Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica;School of Pharmacy;Nanjing University of Chinese Medicine;Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor;
..............page:700-706
Progress in research on relationship between micro RNA-21 and tumors
XU Hua-Lin;ZHAO Juan-juan;ZHENG Wen;LU Jia;LEI Liang-yu;TAO Yi-jing;GUO Meng-meng;LUO Jun-min;XU Lin;Department of Immunology;Zunyi Medical University;Guizhou Innovation Base of Immunology Postgraduate Education;
..............page:707-712